Drug Drug Interaction | List of Frontiers open access articles

Original Research

Published on 29 Apr 2024

The impacts of natural product miltirone and the CYP2D6 pharmacogenetic phenotype on fluoxetine metabolism

in Drug Metabolism and Transport

Xiaodan Zhang
Qingqing Li
Xinwu Ye
Qing Chen
Chen Chen
Guoxin Hu
Likang Zhang
Lianguo Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1373048

2,573 views
5 citations

Review

Published on 22 Jun 2022

Prevention of Anthracycline-Induced Cardiotoxicity: The Good and Bad of Current and Alternative Therapies

in Cardio-Oncology

Nonhlakanipho F. Sangweni
Derick van Vuuren
Lawrence Mabasa
Kwazi Gabuza
Barbara Huisamen
Sharnay Naidoo
Reenen Barry
Rabia Johnson

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.907266

10,106 views
26 citations

Clinical Trial

Published on 08 Sep 2022

Effects of ilaprazole on the steady-state pharmacodynamics of clopidogrel in healthy volunteers: An open-label randomized crossover study

in Drug Metabolism and Transport

Zekang Ye
Pengsheng Chen
Chuchu Tan
Xiaoxuan Gong
Ran Li
Zhou Dong
Inam Ullah
Chen Zhou
Sufeng Zhou
Lijun Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2022.952804

5,202 views
5 citations

Original Research

Published on 08 May 2020

Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross‐Sectional Descriptive Study as Part of the PharmLines Initiative

in Pharmacogenetics and Pharmacogenomics

Muh. Akbar Bahar
Jens H. J. Bos
Sander D. Borgsteede
Aafje Dotinga
Rolinde A. Alingh
Bob Wilffert
Eelko Hak

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00624

4,495 views
2 citations

Original Research

Published on 08 Dec 2021

Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus

in Experimental Pharmacology and Drug Discovery

Bui Thi Bich Hanh
Nguyen Thanh Quang
Yujin Park
Bo Eun Heo
Seunghyeon Jeon
June-Woo Park
Jichan Jang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.790767

7,281 views
28 citations

General Commentary

Published on 29 Jun 2023

Commentary: Potentially inappropriate medication among older patients with diabetic kidney disease

in Pharmacoepidemiology

M. I. Danjuma
R. Sayed
I. Elzouki

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1210331

2,199 views

Original Research

Published on 23 Aug 2022

Concurrent Use of Oral Anticoagulants and Sulfonylureas in Individuals With Type 2 Diabetes and Risk of Hypoglycemia: A UK Population-Based Cohort Study

in Regulatory Science

Hassan Alwafi
Ian C. K. Wong
Abdallah Y. Naser
Amitava Banerjee
Pajaree Mongkhon
Cate Whittlesea
Alaa Alsharif
Li Wei

Frontiers in Medicine

doi 10.3389/fmed.2022.893080

5,916 views
5 citations

Review

Published on 29 Sep 2020

Cannabidiol Treatment for Refractory Epilepsies in Pediatrics

in Neuropharmacology

Umberto Raucci
Nicola Pietrafusa
Maria Chiara Paolino
Giovanni Di Nardo
Maria Pia Villa
Piero Pavone
Gianluca Terrin
Nicola Specchio
Pasquale Striano
Pasquale Parisi

Frontiers in Pharmacology

doi 10.3389/fphar.2020.586110

22,512 views
40 citations

Articles

The impacts of natural product miltirone and the CYP2D6 pharmacogenetic phenotype on fluoxetine metabolism

Prevention of Anthracycline-Induced Cardiotoxicity: The Good and Bad of Current and Alternative Therapies

Effects of ilaprazole on the steady-state pharmacodynamics of clopidogrel in healthy volunteers: An open-label randomized crossover study

Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross‐Sectional Descriptive Study as Part of the PharmLines Initiative

Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus

Commentary: Potentially inappropriate medication among older patients with diabetic kidney disease

Concurrent Use of Oral Anticoagulants and Sulfonylureas in Individuals With Type 2 Diabetes and Risk of Hypoglycemia: A UK Population-Based Cohort Study

Cannabidiol Treatment for Refractory Epilepsies in Pediatrics